beta-alanine has been researched along with Activated Protein C Resistance in 2 studies
Activated Protein C Resistance: A hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC). The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Assays that include dilution into factor V-deficient plasma are needed to avoid interference from factor deficiencies or elevations, which can arise from a wide variety of conditions such as warfarin, liver dysfunction, or pregnancy." | 3.80 | Activated protein C resistance testing for factor V Leiden. ( Kadauke, S; Khor, B; Van Cott, EM, 2014) |
| " Dabigatran was added to plasma from healthy subjects in the concentration range 0-1,000 μg/l and analysed using several reagents for activated thromboplastin time (APTT), prothrombin time (PT), fibrinogen, antithrombin, and activated protein C resistance." | 3.77 | Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays. ( Baghaei, F; Blixter, IF; Gustafsson, KM; Hillarp, A; Lindahl, TL; Sten-Linder, M; Stigendal, L; Strandberg, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadauke, S | 1 |
| Khor, B | 1 |
| Van Cott, EM | 1 |
| Lindahl, TL | 1 |
| Baghaei, F | 1 |
| Blixter, IF | 1 |
| Gustafsson, KM | 1 |
| Stigendal, L | 1 |
| Sten-Linder, M | 1 |
| Strandberg, K | 1 |
| Hillarp, A | 1 |
2 other studies available for beta-alanine and Activated Protein C Resistance
| Article | Year |
|---|---|
Activated protein C resistance testing for factor V Leiden.
Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biolog | 2014 |
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Topics: Activated Protein C Resistance; Administration, Oral; Adult; Aged; Antithrombins; Benzimidazoles; be | 2011 |